BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37562091)

  • 21. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
    Li W; Cao L; Chen X; Lei J; Ma Q
    Oncol Rep; 2016 Mar; 35(3):1718-26. PubMed ID: 26707376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
    Bi YL; Min M; Shen W; Liu Y
    Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway.
    Jia F; Liu Y; Dou X; Du C; Mao T; Liu X
    Oxid Med Cell Longev; 2022; 2022():8245614. PubMed ID: 35116094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bigelovin, a sesquiterpene lactone, suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation in liver cancer.
    Wang B; Zhou TY; Nie CH; Wan DL; Zheng SS
    Biochem Biophys Res Commun; 2018 May; 499(2):156-163. PubMed ID: 29548826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triggering of Apoptosis in Osteosarcoma 143B Cell Line by Carbon Quantum Dots via the Mitochondrial Apoptotic Signal Pathway.
    Jiao Y; Guo Y; Fan Y; Wang R; Li X; Wu H; Meng Z; Yang X; Cui Y; Liu H; Pan L; Maimaitijuma T; Zhang J; Wang Y; Cao Y; Zhang T
    Biomed Res Int; 2020; 2020():2846297. PubMed ID: 32733936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (-)-Xanthatin induces the prolonged expression of c-Fos through an N-acetyl-L-cysteine (NAC)-sensitive mechanism in human breast cancer MDA-MB-231 cells.
    Takeda S; Nishimura H; Koyachi K; Matsumoto K; Yoshida K; Okamoto Y; Amamoto T; Shindo M; Aramaki H
    J Toxicol Sci; 2013; 38(4):547-57. PubMed ID: 23824011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FABP4 Regulates Cell Proliferation, Stemness, Apoptosis, and Glycolysis in Colorectal Cancer via Modulating ROS/ERK/mTOR Pathway.
    Gao Y; Wang Y; Wang X; Ma J; Wei M; Li N; Zhao Z
    Discov Med; 2023 Jun; 35(176):361-371. PubMed ID: 37272103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
    Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
    Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Piceatannol induces apoptotic cell death through activation of caspase-dependent pathway and upregulation of ROS-mediated mitochondrial dysfunction in pancreatic cancer cells.
    Çınar Ayan İ; Güçlü E; Vural H; Dursun HG
    Mol Biol Rep; 2022 Dec; 49(12):11947-11957. PubMed ID: 36260179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valtrate as a novel therapeutic agent exhibits potent anti-pancreatic cancer activity by inhibiting Stat3 signaling.
    Chen L; Feng D; Qian Y; Cheng X; Song H; Qian Y; Zhang X; Wu Y; Lv H; Liu Q; Cheng G; Yang B; Gu M
    Phytomedicine; 2021 May; 85():153537. PubMed ID: 33744595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis.
    Shi Y; Sahu RP; Srivastava SK
    BMC Cancer; 2008 Oct; 8():294. PubMed ID: 18847491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prosopis juliflora (Sw.) DC phytochemicals induce apoptosis and inhibit cell proliferation signaling pathways, EMT, migration, invasion, angiogenesis and stem cell markers in melanoma cell lines.
    Choudhari J; Nimma R; Nimal SK; Totakura Venkata SK; Kundu GC; Gacche RN
    J Ethnopharmacol; 2023 Aug; 312():116472. PubMed ID: 37062530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sophoridine induces apoptosis and S phase arrest via ROS-dependent JNK and ERK activation in human pancreatic cancer cells.
    Xu Z; Zhang F; Bai C; Yao C; Zhong H; Zou C; Chen X
    J Exp Clin Cancer Res; 2017 Sep; 36(1):124. PubMed ID: 28893319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saikosaponin-A Exhibits Antipancreatic Cancer Activity by Targeting the EGFR/PI3K/Akt Pathway.
    Shi C; Sun L; Fang R; Zheng S; Yu M; Li Q
    Curr Pharm Biotechnol; 2023; 24(4):579-588. PubMed ID: 35692139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological activities of xanthatin from Xanthium strumarium leaves.
    Nibret E; Youns M; Krauth-Siegel RL; Wink M
    Phytother Res; 2011 Dec; 25(12):1883-90. PubMed ID: 21953905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dihydrotanshinone I Inhibits Pancreatic Cancer Progression
    Huang W; Dai Y; Xu L; Mao Y; Huang Z; Ji X
    Curr Cancer Drug Targets; 2023; 23(9):731-741. PubMed ID: 37018533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concerted suppression of STAT3 and GSK3β is involved in growth inhibition of non-small cell lung cancer by Xanthatin.
    Tao L; Fan F; Liu Y; Li W; Zhang L; Ruan J; Shen C; Sheng X; Zhu Z; Wang A; Chen W; Huang S; Lu Y
    PLoS One; 2013; 8(11):e81945. PubMed ID: 24312384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (--)-Xanthatin selectively induces GADD45γ and stimulates caspase-independent cell death in human breast cancer MDA-MB-231 cells.
    Takeda S; Matsuo K; Yaji K; Okajima-Miyazaki S; Harada M; Miyoshi H; Okamoto Y; Amamoto T; Shindo M; Omiecinski CJ; Aramaki H
    Chem Res Toxicol; 2011 Jun; 24(6):855-65. PubMed ID: 21568272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glaucocalyxin A impairs tumor growth via amplification of the ATF4/CHOP/CHAC1 cascade in human oral squamous cell carcinoma.
    Wang X; He MJ; Chen XJ; Bai YT; Zhou G
    J Ethnopharmacol; 2022 May; 290():115100. PubMed ID: 35151835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resibufogenin suppresses growth and metastasis through inducing caspase-1-dependent pyroptosis via ROS-mediated NF-κB suppression in non-small cell lung cancer.
    Yin H; Liu YG; Li F; Wang LQ; Zha JH; Xia YC; Yu BT; Wen DH
    Anat Rec (Hoboken); 2021 Feb; 304(2):302-312. PubMed ID: 32396707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.